The Dualistic Nature of Immune Modulation In Alzheimer's Disease: Lessons from the Transgenic Models

E-ISSN： 1873-4286|11|26|3335-3352

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.26, 2005-10, pp. : 3335-3352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer’s disease: transgenic mouse models and drug assessment

By Yu P. Oberto G.

Pharmacological Research, Vol. 42, Iss. 2, 2000-08 ,pp. : 107-114

Academic Press

Access to resources Recommend Favorite

Interacting with γSecretase for Treating Alzheimer's Disease: From Inhibition to Modulation

Current Medicinal Chemistry, Vol. 18, Iss. 35, 2011-12 ,pp. : 5430-5447

Bentham Science Publishers

Access to resources Recommend Favorite

Transgenic Mouse Models of Alzheimer Disease: Developing a Better Model as a Tool for Therapeutic Interventions

Current Pharmaceutical Design, Vol. 18, Iss. 8, 2012-03 ,pp. : 1131-1147

Bentham Science Publishers

Access to resources Recommend Favorite

Transgenic animal model for Alzheimer’s disease

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 729-732

Informa Healthcare

Access to resources Recommend Favorite

Transgenic Mouse Models of Parkinson's Disease and Huntington's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 4, 2010-08 ,pp. : 455-470

Bentham Science Publishers

Access to resources Recommend Favorite